NEVVI Medicare utilization intelligence
or

← back

Provider profile

GOLDSTEIN, MARK MD

Hematology-Oncology · NPI 1649216342 · GERMANTOWN, MD

1
Groups
27
Codes · 2024
29,260
Disclosed services

GOLDSTEIN, MARK is a Hematology-Oncology in GERMANTOWN, MD, a member of 1 medical group, who billed 27 distinct codes to Medicare Part B in 2024.

Groups: AMERICAN ONCOLOGY PARTNERS PA (FORT WAYNE, IN)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

29,260
disclosed services
27
codes billed to Medicare Part B
Prior year · CY2023 37,002 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J1437 Injection, ferric derisomaltose, 10 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J2405 Injection, ondansetron hydrochloride, per 1 mg
96375 Injection of additional new drug or substance into vein
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
96372 Injection of drug or substance under skin or into muscle
96413 Administration of chemotherapy into vein, 1 hour or less
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
82728 Ferritin (blood protein) level
83540 Iron level
85045 Red blood count, automated test
80053 Blood test, comprehensive group of blood chemicals
J1200 Injection, diphenhydramine hcl, up to 50 mg
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
J3490 Unclassified drugs
83615 Lactate dehydrogenase (enzyme) level
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
38222 Biopsy and aspiration of bone marrow sample for diagnosis

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.